As Board Chairman I have the privilege to work with a diverse and talented group of Board Members and Advisers tasked to guide and oversee this industry leading e-commerce healthcare company. Our group includes best-in-class professionals with extensive backgrounds in healthcare, technology, finance and government policy making.My primary responsibilities are to increase shareholder value, provide guidance to our C-level executives, establish benchmarks for accountability and define by example our corporate culture. MDsave is a consumer choice driven e-commerce healthcare company. We disrupt the status quo by delivering price transparency via our unique, patented technology. The goal is to efficiently and economically introduce cost conscious, tech-savvy consumers with the best healthcare service providers by creating a national network of quality medical services. Potential patients will have unprecedented access to value-priced services with the power to choose care based on quality and price. The company serves patients and businesses with high deductible based insurance plans significant savings for top quality care with typical savings of 60%. MDsave has exceeded projections and expectations every quarter since inception. The company currently has hundreds of service providers in over 36 states and now has a national network of quality healthcare providers serving thousands of patients each month. Sales continue to set new records every month with our brand rapidly growing with consumers and businesses. Please visit our MDsave LinkedIn site at http://www.linkedin.com/company/mdsave-inc for more information on up-to-date activities, business expansion and recent awards.

Since its inception Great South Surgical Solutions, Inc. (GS3) represented premier quality lines of medical capital equipment and surgical services. The company gained significant market share and was focused on expanding distribution of quality products and services throughout the United States. These goals were achieved by adhering to three keys to success - market power, customer satisfaction and good management.In 2020 there will have a new corporation direction and purpose. Rather than products and services, GS3 will serve as a holding company for the various and growing investment vehicles owned by its founder and his family. Having served as CEO for nearly 14-years I will now oversee and manage family investments as Executive Management Director.

Diagnostix Network Alliance (DNA) is a bio-technology sales organization representing a revolutionary technology which is the fastest, most accurate and effective method available to identify multiple infectious pathogens using molecular multiplexing. This proprietary testing process, provided by DIATHERIX Laboratories, is a molecular differential diagnostic (MDD) tool trademarked as Tem-PCR™, an acronym for “Target Enhanced Multiplexing”. DIATHERIX Laboratories’ licensed breakthrough technology Tem-PCR uses multiple specific genetic targets to identify different pathogens in a single molecular test.